LEXX logo

Lexaria Bioscience (LEXX) CAPEX

Annual CAPEX

$188.60 K
+$19.00 K+11.20%

August 31, 2024

Summary

Performance

1-Year Change

+11.2%

3-Year Change

+137.23%

5-Year Change

-75.48%

15-Year Change

+1844.33%

LEXX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.22%
LEXX annual capital expenditures is higher than 17.22% of companies in Healthcare sector

High & Low

All-time High

$2.09 M
LEXX annual capital expenditures is currently -90.97% below its historical high of $2.09 million

3-Year Low

$79.50 K
LEXX annual capital expenditures is currently +137.23% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Aug 31, 2024
LEXX previous annual earnings announcement was published on Aug 31, 2024

Next Annual Earnings Report Date

N/A
LEXX next annual earnings announcement has not yet been scheduled

OtherLEXXcash flowmetrics:

Annual FCF

-$5.15 M
LEXX annual free cash flow is -$5.15 million

Annual CFO

-$4.96 M
LEXX annual cash flow from operations is -$4.96 million

Annual CFI

-$188.60 K
LEXX annual cash flow from investing activities is -$188.60 thousand

Annual CFF

$10.32 M
LEXX annual cash flow from financing activities is $10.32 million

Quarterly CAPEX

$37.80 K
-$31.80 K-45.69%

November 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+8.62%

5-Year Change

+8.62%

LEXX Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.4%
LEXX quarterly capital expenditures is higher than 21.4% of companies in Healthcare sector

High & Low

All-time High

$834.50 K
LEXX quarterly capital expenditures is currently -95.47% below its historical high of $834.50 thousand

3-Year Low

$22.00 K
LEXX quarterly capital expenditures is currently +71.82% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Nov 30, 2024
LEXX previous earnings announcement was published on Nov 30, 2024

Next Quarterly Earnings Report Date

Apr 9, 2025
LEXX next earnings announcement is scheduled for Apr 9, 2025

OtherLEXXcash flowmetrics:

Quarterly FCF

-$2.76 M
LEXX quarterly free cash flow is -$2.76 million

Quarterly CFO

-$2.73 M
LEXX quarterly cash flow from operations is -$2.73 million

Quarterly CFI

-$37.80 K
LEXX quarterly cash flow from investing activities is -$37.80 thousand

Quarterly CFF

$4.35 M
LEXX quarterly cash flow from financing activities is $4.35 million

TTM CAPEX

$186.40 K
-$2200.00-1.17%

November 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+18.58%

5-Year Change

+18.58%

LEXX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

15.87%
LEXX TTM capital expenditures is higher than 15.87% of companies in Healthcare sector

High & Low

All-time High

$2.09 M
LEXX TTM capital expenditures is currently -91.08% below its historical high of $2.09 million

3-Year Low

$130.60 K
LEXX TTM capital expenditures is currently +42.73% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Nov 30, 2024
LEXX previous earnings announcement was published on Nov 30, 2024

Next Quarterly Earnings Report Date

Apr 9, 2025
LEXX next earnings announcement is scheduled for Apr 9, 2025

OtherLEXXcash flowmetrics:

TTM FCF

-$6.69 M
LEXX TTM free cash flow is -$6.69 million

TTM CFO

-$6.50 M
LEXX TTM cash flow from operations is -$6.50 million

TTM CFI

-$186.40 K
LEXX TTM cash flow from investing activities is -$186.40 thousand

TTM CFF

$12.84 M
LEXX TTM cash flow from financing activities is $12.84 million

LEXX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.2%0.0%0.0%
3 y3 years+137.2%+8.6%+18.6%
5 y5 years-75.5%+8.6%+18.6%

LEXX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+137.2%-45.7%+71.8%-6.3%+42.7%
5 y5-year-75.5%+461.3%-46.5%-100.0%-33.0%+454.8%
alltimeall time-91.0%+1844.3%-95.5%+130.4%-91.1%+1821.7%

Lexaria Bioscience CAPEX History

DateAnnualQuarterlyTTM
Nov 2024
-
$37.80 K(-45.7%)
$186.40 K(-1.2%)
Aug 2024
$188.60 K(+11.2%)
$69.60 K(+216.4%)
$188.60 K(+0.6%)
May 2024
-
$22.00 K(-61.4%)
$187.40 K(-5.8%)
Feb 2024
-
$57.00 K(+42.5%)
$199.00 K(+13.9%)
Nov 2023
-
$40.00 K(-41.5%)
$174.70 K(+3.1%)
Aug 2023
$169.60 K(-6.1%)
$68.40 K(+103.6%)
$169.50 K(+12.2%)
May 2023
-
$33.60 K(+2.8%)
$151.10 K(-2.8%)
Feb 2023
-
$32.70 K(-6.0%)
$155.50 K(-1.1%)
Nov 2022
-
$34.80 K(-30.4%)
$157.20 K(-13.0%)
Aug 2022
$180.60 K(+127.2%)
$50.00 K(+31.6%)
$180.60 K(+38.3%)
May 2022
-
$38.00 K(+10.5%)
$130.60 K(-20.0%)
Feb 2022
-
$34.40 K(-40.9%)
$163.30 K(+23.8%)
Nov 2021
-
$58.20 K(>+9900.0%)
$131.90 K(+65.9%)
Aug 2021
$79.50 K(+136.6%)
$0.00(-100.0%)
$79.50 K(-14.6%)
May 2021
-
$70.70 K(+2256.7%)
$93.10 K(+153.7%)
Feb 2021
-
$3000.00(-48.3%)
$36.70 K(+8.9%)
Nov 2020
-
$5800.00(-57.4%)
$33.70 K(+0.3%)
Aug 2020
$33.60 K(-95.6%)
$13.60 K(-4.9%)
$33.60 K(-36.7%)
May 2020
-
$14.30 K(>+9900.0%)
$53.10 K(-80.9%)
Feb 2020
-
$0.00(-100.0%)
$278.00 K(-54.3%)
Nov 2019
-
$5700.00(-82.8%)
$607.70 K(-21.0%)
Aug 2019
$769.20 K(+800.7%)
$33.10 K(-86.2%)
$769.20 K(+0.8%)
May 2019
-
$239.20 K(-27.4%)
$762.90 K(+38.6%)
Feb 2019
-
$329.70 K(+97.2%)
$550.30 K(+132.3%)
Nov 2018
-
$167.20 K(+523.9%)
$236.90 K(+177.4%)
Aug 2018
$85.40 K(+780.4%)
$26.80 K(+0.8%)
$85.40 K(+45.7%)
May 2018
-
$26.60 K(+63.2%)
$58.60 K(+83.1%)
Feb 2018
-
$16.30 K(+3.8%)
$32.00 K(+173.5%)
Nov 2017
-
$15.70 K(>+9900.0%)
$11.70 K(+20.6%)
Aug 2017
$9700.00(-51.7%)
$0.00(0.0%)
$9700.00(-32.6%)
May 2017
-
$0.00(-100.0%)
$14.40 K(-2.0%)
Feb 2017
-
-$4000.00(-129.2%)
$14.70 K(-52.1%)
Nov 2016
-
$13.70 K(+191.5%)
$30.70 K(+52.7%)
Aug 2016
$20.10 K
$4700.00(+1466.7%)
$20.10 K(+76.3%)
DateAnnualQuarterlyTTM
May 2016
-
$300.00(-97.5%)
$11.40 K(-78.1%)
Feb 2016
-
$12.00 K(+287.1%)
$52.10 K(+29.9%)
Nov 2015
-
$3100.00(-177.5%)
$40.10 K(+8.4%)
Aug 2015
$37.00 K(-46.1%)
-$4000.00(-109.8%)
$37.00 K(-9.8%)
May 2015
-
$41.00 K(>+9900.0%)
$41.00 K(-51.0%)
Aug 2014
$68.60 K(-25.1%)
-
-
Jul 2014
-
$0.00(-100.0%)
$83.60 K(-0.1%)
Apr 2014
-
$31.40 K(+25.6%)
$83.70 K(+5.4%)
Jan 2014
-
$25.00 K(-8.1%)
$79.40 K(-13.2%)
Oct 2013
$91.60 K(-66.6%)
$27.20 K(>+9900.0%)
$91.50 K(+0.2%)
Jul 2013
-
$100.00(-99.6%)
$91.30 K(-68.9%)
Apr 2013
-
$27.10 K(-27.0%)
$293.10 K(+10.2%)
Jan 2013
-
$37.10 K(+37.4%)
$266.00 K(-3.0%)
Oct 2012
$274.10 K(-72.7%)
$27.00 K(-86.6%)
$274.10 K(-71.7%)
Jul 2012
-
$201.90 K(>+9900.0%)
$968.60 K(+26.3%)
Apr 2012
-
$0.00(-100.0%)
$766.70 K(-4.9%)
Jan 2012
-
$45.20 K(-93.7%)
$806.00 K(-19.6%)
Oct 2011
$1.00 M(+251.5%)
$721.50 K(>+9900.0%)
$1.00 M(+256.6%)
Jul 2011
-
$0.00(-100.0%)
$281.20 K(0.0%)
Apr 2011
-
$39.30 K(-83.8%)
$281.20 K(+16.2%)
Jan 2011
-
$241.90 K(+119.3%)
$241.90 K(+8.1%)
Oct 2010
$285.20 K(+27.4%)
-
-
Oct 2009
$223.80 K(-61.6%)
$110.30 K(+970.9%)
$223.80 K(+46.5%)
Jul 2009
-
$10.30 K(-84.6%)
$152.80 K(-49.7%)
Apr 2009
-
$67.10 K(+85.9%)
$303.80 K(+170.5%)
Jan 2009
-
$36.10 K(-8.1%)
$112.30 K(-80.7%)
Oct 2008
$582.40 K(-72.1%)
$39.30 K(-75.6%)
$582.40 K(-57.2%)
Jul 2008
-
$161.30 K(-229.7%)
$1.36 M(+12.7%)
Apr 2008
-
-$124.40 K(-124.6%)
$1.21 M(-31.5%)
Jan 2008
-
$506.20 K(-38.0%)
$1.76 M(-15.7%)
Oct 2007
$2.09 M(+36.5%)
$816.10 K(>+9900.0%)
$2.09 M(+64.1%)
Jul 2007
-
$7700.00(-98.2%)
$1.27 M(+0.6%)
Apr 2007
-
$430.40 K(-48.4%)
$1.26 M(+51.6%)
Jan 2007
-
$834.50 K
$834.50 K
Oct 2006
$1.53 M
-
-

FAQ

  • What is Lexaria Bioscience annual capital expenditures?
  • What is the all time high annual CAPEX for Lexaria Bioscience?
  • What is Lexaria Bioscience annual CAPEX year-on-year change?
  • What is Lexaria Bioscience quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Lexaria Bioscience?
  • What is Lexaria Bioscience quarterly CAPEX year-on-year change?
  • What is Lexaria Bioscience TTM capital expenditures?
  • What is the all time high TTM CAPEX for Lexaria Bioscience?
  • What is Lexaria Bioscience TTM CAPEX year-on-year change?

What is Lexaria Bioscience annual capital expenditures?

The current annual CAPEX of LEXX is $188.60 K

What is the all time high annual CAPEX for Lexaria Bioscience?

Lexaria Bioscience all-time high annual capital expenditures is $2.09 M

What is Lexaria Bioscience annual CAPEX year-on-year change?

Over the past year, LEXX annual capital expenditures has changed by +$19.00 K (+11.20%)

What is Lexaria Bioscience quarterly capital expenditures?

The current quarterly CAPEX of LEXX is $37.80 K

What is the all time high quarterly CAPEX for Lexaria Bioscience?

Lexaria Bioscience all-time high quarterly capital expenditures is $834.50 K

What is Lexaria Bioscience quarterly CAPEX year-on-year change?

Over the past year, LEXX quarterly capital expenditures has changed by $0.00 (0.00%)

What is Lexaria Bioscience TTM capital expenditures?

The current TTM CAPEX of LEXX is $186.40 K

What is the all time high TTM CAPEX for Lexaria Bioscience?

Lexaria Bioscience all-time high TTM capital expenditures is $2.09 M

What is Lexaria Bioscience TTM CAPEX year-on-year change?

Over the past year, LEXX TTM capital expenditures has changed by $0.00 (0.00%)